Evusheld

(asked on 2nd September 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish the findings to date from the Department's review of the efficacy of Evusheld.


Answered by
Robert Jenrick Portrait
Robert Jenrick
This question was answered on 27th September 2022

The Government has decided not to procure Evusheld for prevention through emergency routes at this time. This is a decision based on independent clinical advice by the multi-agency RAPID C-19 and a United Kingdom national expert policy working group. These groups considered a range of evidence, including clinical trial data, in vitro analysis and emerging observational studies and concluded there is currently insufficient evidence of benefit to recommend deployment. The UK Chief Medical Officers are content that the correct process for providing clinical advice has been followed and it should be referred to the National Institute for Health and Care Excellence for further evaluation.

The Department wrote to patient groups on 5 September 2022 on this decision and the evidence considered. The Department intends to publish further details of the clinical advice received shortly.

Reticulating Splines